CARE FOR ALL：an Evaluation of an asthma QIP

Trial Identifier: D589BC00027
Sponsor: AstraZeneca
NCTID:: NCT05440097
Start Date: July 2022
Primary Completion Date: June 2024
Study Completion Date: June 2024
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, 100020
CN Beijing, CN, 100080
CN Beijing, CN, 100050
CN Changchun, CN, 130033
CN changsha, CN, 410005
CN Changzhi, CN, 046000
CN Chengdu, CN, 610021
CN Chongqing, CN, 404197
CN Dalian, CN, 116011
CN Foshan, CN, 528315
CN Guangzhou, CN, 510620
CN Handan, CN, 056000
CN Harbin, CN, 150001
CN Hebi, CN, 458000
CN Hefei, CN, 230011
CN Huai'an, CN, 223000
CN Jinan, CN, 250031
CN Jinhua, CN, 322100
CN Kunming, CN, 650051
CN Kunshan, CN, 215316
CN Nanchang, CN, 331700
CN nanning, CN
CN Ningbo, CN, 315040
CN Shanghai, CN, 200030
CN Shanghai, CN, 200080
CN shiyan, CN, 442005
CN Taizhou, CN, 317100
CN Tianjin, CN, 300450
CN Wuhu, CN, 241000
CN Wuyishan, CN, 354300
CN Xi'an, CN, 710038
CN Yantai, CN, 265701